Patents by Inventor Horst Kagelmaker

Horst Kagelmaker has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • Patent number: 4882127
    Abstract: A device for solid phase sequencing of nucleic acid segments comprises a plurality of sequencing blocks for storaging and processing n nucleic acid fragments immobilized on carrier segments or in homogenous phase during a sequencing process, each of a sample dosing device for immobilizing n labeled nucleic acid samples from the sequencing blocks onto areas of a carrier matrix in a simultaneous fashion and including a capillary holder and a plurality of capillaries corresponding to the number n of different nucleic acid samples to be sequences and arranged according to the distribution of the reaction vessels with a distance between capillary orifices from the capillary holder greater than a depth of the reaction vessels, a plurality of carrier holders for fixing carrier matrices in a predetermined position during the immobilization of the nucleic acid samples with the sample dosing device and each having a recess corresponding to respective dimensions of the carrier matrix and a plurality of bores with a numb
    Type: Grant
    Filed: November 12, 1987
    Date of Patent: November 21, 1989
    Assignee: Akademie Der Wissenschaften Der DDR
    Inventors: Andre Rosenthal, Hans-Dieter Hunger, Horst Kagelmaker, Monika Gratschus
  • Patent number: 4849077
    Abstract: A process for solid phase sequencing of nucleic acid fragments is disclosed. The object of the invention is to provide a sequencing process which enables the simultaneous sequencing of large amounts of long and short nucleic acid fragments and which is optionally automated. Thus, a solid support combining mechanical stability, anion exchange characteristics, and chemical elution of nucleic acids off the support is used. Immobilized nucleic acid fragments are chemically modified and subsequently the nucleic acid backbone is cleaved and simultaneously or subsequently said fragments are eluted by chemical means. The present invention is applied to molecular biology and gene technology.
    Type: Grant
    Filed: July 31, 1985
    Date of Patent: July 18, 1989
    Assignee: Akademie der Wissenschaften der DDR
    Inventors: Andre Rosenthal, Hans-Dieter Hunger, Horst Kagelmaker, Monika Graatschus